News
Feed
Events
Feed
News
+ Events
Feed

iCo Therapeutics Inc.

  • ISIN CA45107J1057

Aktuelle News

19 August 2019

14:03 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Inc. Announces the Issuance of 41,200,000 Units Pursuant to its Non-Brokered Private Placement

7 August 2019

04:47 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Provides Corporate Update

28 Juni 2019

14:03 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces AGM Voting Results

30 Mai 2019

22:41 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces First Quarter 2019 Financial Results

1 Mai 2019

00:39 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces 2018 Year End Financial Results

25 Februar 2019

14:01 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Inc. Announces the Issuance of 14,400,000 Units Pursuant to its C$1,250,000 Non-Brokered Private Placement

19 Februar 2019

12:01 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Inc. Announces Upsizing of Non-Brokered Private Placement to $1,250,000 CDN

12 Februar 2019

01:20 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Inc. Announces the Issuance of 4,000,000 Units Pursuant to its C$750,000 Non-Brokered Private Placement

1 Februar 2019

02:07 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Inc. Announces Non-Brokered Private Placement to Raise C$750,000

29 November 2018

23:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Update

15 November 2018

14:01 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Provides Corporate Update, Including Drug Supply for Next Oral Amphotericin B Efficacy Study

23 Oktober 2018

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Oral Amphotericin B Clinical Advisory Board

2 Oktober 2018

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Provides Corporate Update

6 September 2018

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Additional Positive Pharmacokinetic Results and Presentation at Global Investment Conference

30 August 2018

00:32 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Second Quarter 2018 Financial Results And Corporate Update

16 Juli 2018

14:01 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Positive Secondary Endpoint and Advancement into Later Stage Clinical Trials – Phase 1 Oral Amphotericin B

27 Juni 2018

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Positive Clinical Outcome – Primary Endpoint Met in Phase 1 Oral Amphotericin B Study

20 Juni 2018

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Provides Corporate Update, Announces Completion of Phase 1 Recruitment

30 Mai 2018

22:19 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces First Quarter 2018 Financial Results And Update On Phase 1 Clinical Trial

25 April 2018

02:47 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Year End 2017 Financial Results

18 April 2018

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Major Milestone – Dosing of First Patient for its Oral Amphotericin B Phase 1 Clinical Study

22 November 2017

19:20 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Ethics Approval for its Oral Amphotericin B Phase 1 Clinical Study

8 September 2017

01:11 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Upcoming Presentations and Meetings

29 August 2017

23:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Second Quarter 2017 Financial Results

15 Juni 2017

22:15 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Pre IND meeting for Novel Glaucoma Asset

12 Juni 2017

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Positive Oral Amphotericin Study

23 Januar 2017

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Provides Multiple Corporate Updates

28 November 2016

17:53 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

CLARIFICATION: iCo Therapeutics Announces Positive Study Results and Significant Advances related to Oral Amphotericin B Program

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Positive Study Results and Significant Advances Related to Oral Amphotericin B Program

24 November 2016

14:00 Corporate EN

iCo Therapeutics Inc.

Corporate
EN

iCo Therapeutics Announces Third Quarter 2016 Financial Results

Anstehende Events

Keine Events gefunden